Bouhafa T, Masbah O, Bekkouch I, Afqir S, Mellas N, Ismaili N, Hassouni K, Kebdani T, Jalil A, Benjaafar N, Errihani H, Elgueddari B
Department of Radiotherapy, National Institute of Oncology, rue Allal-El-Fassi, BP 3213, Rabat, Maroc.
Cancer Radiother. 2009 Apr;13(2):85-91. doi: 10.1016/j.canrad.2008.11.007. Epub 2008 Dec 31.
Phyllode tumors of the breast are fibroepithelial tumors similar to fibroadenomas but with a predominant conjunctive tissue component. These are composed of a connective tissue stroma and epithelial elements. They are rare with an incidence of 0.3-0.9% of all breast neoplasms. The present study demonstrates the recent experiences in diagnosis, therapeutical management and clinical follow-up of this disease.
This is a retrospective study of the experience of the Institut National d'Oncologie (INO, Rabat) from 1998 to 2006.
We included 53 patients. Median age was 37.2 years (15-67), tumor size was 1-30cm (median 10.25cm). The histological diagnosis was based on the biopsy in (7.8%) cases and extemporany in 22% cases, distant metastasis occurred in two patients; the treatment consisted of a surgery. The median follow-up was three years. Local recurrence occurred in ten patients. Distant metastasis occurred in two patients and five patients have died.
The confrontation of our results to the data of the international literature shows that the diagnosis of the phyllodes tumours is histological. The basis of the treatment is surgery. The adjuvant radiotherapy is very important in patients at high risk for local recurrence; chemotherapy has a badly defined place. The prognostic is based on the histological characters of the tissue conjunctive component of these tumours.
乳腺叶状肿瘤是一种纤维上皮性肿瘤,与纤维腺瘤相似,但以结缔组织成分为主。它们由结缔组织间质和上皮成分组成。这种肿瘤较为罕见,占所有乳腺肿瘤的0.3 - 0.9%。本研究展示了该疾病在诊断、治疗管理及临床随访方面的最新经验。
这是一项对拉巴特国家肿瘤研究所1998年至2006年经验的回顾性研究。
我们纳入了53例患者。中位年龄为37.2岁(15 - 67岁),肿瘤大小为1 - 30厘米(中位值10.25厘米)。组织学诊断在7.8%的病例中基于活检,22%的病例基于术中检查,两名患者发生远处转移;治疗方式为手术。中位随访时间为三年。10例患者出现局部复发。两名患者发生远处转移,5例患者死亡。
将我们的结果与国际文献数据对比显示,叶状肿瘤的诊断依赖组织学检查。治疗的基础是手术。辅助放疗对局部复发高危患者非常重要;化疗的作用尚不明确。预后取决于这些肿瘤结缔组织成分的组织学特征。